Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released Mar 18, 2013, during market hours
10-K filed Mar 18, 2013, 77 days after period end · 0001193125-13-112305
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|
| Revenue | $28.25M | $29.03M | — |
| Net Income | $1.20M | $738.00K | — |
| EPS Diluted | $0.04 | $0.02 | — |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
